Lung Cancers Withdrawn Phase 2 Trials for Sunitinib (DB01268)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00748163Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung CancerTreatment